- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
BEOVU - 120mg/ml - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S01LA06 | BioTech | Brolucizumab - 120mg/ml | 10436 | 81520/1 | BEOVU | 120mg/ml | 1 | Injectable solution | Ophtalmic | Khalil Fattal & Fils S.A.L. | SA Alcon Couvreur NV | Belgium | 68,669,378 L.L | 10.71 | E1 | Novartis Europharm Limited | Ireland | 2/5/2024 | 0 |